Detailed Information on Publication Record
2015
Paramagnetic Nanoparticles as a Platform for FRET-Based Sarcosine Picomolar Detection
HEGER, Zbynek, Natalia CERNEI, Sona KRIZKOVA, Michal MASAŘÍK, Pavel KOPEL et. al.Basic information
Original name
Paramagnetic Nanoparticles as a Platform for FRET-Based Sarcosine Picomolar Detection
Authors
HEGER, Zbynek (203 Czech Republic), Natalia CERNEI (203 Czech Republic), Sona KRIZKOVA (203 Czech Republic), Michal MASAŘÍK (203 Czech Republic, guarantor, belonging to the institution), Pavel KOPEL (203 Czech Republic), Petr HODEK (203 Czech Republic), Ondrej ZITKA (203 Czech Republic), Vojtech ADAM (203 Czech Republic) and Rene KIZEK (203 Czech Republic)
Edition
Scientific Reports, London, Nature Publishing Group, 2015, 2045-2322
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30105 Physiology
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 5.228
RIV identification code
RIV/00216224:14110/15:00083933
Organization unit
Faculty of Medicine
UT WoS
000350549200018
Keywords in English
Prostate-cancer progression; Urine samples; Diagnostics; Carcinoma
Tags
Tags
International impact, Reviewed
Změněno: 22/9/2015 14:38, Soňa Böhmová
Abstract
V originále
Herein, we describe an ultrasensitive specific biosensing system for detection of sarcosine as a potential biomarker of prostate carcinoma based on Forster resonance energy transfer (FRET). The FRET biosensor employs anti-sarcosine antibodies immobilized on paramagnetic nanoparticles surface for specific antigen binding. Successful binding of sarcosine leads to assembly of a sandwich construct composed of anti-sarcosine antibodies keeping the Forster distance (Ro) of FRET pair in required proximity. The detection is based on spectral overlap between gold-functionalized green fluorescent protein and antibodies@quantum dots bioconjugate (lambda(ex) 400 nm). The saturation curve of sarcosine based on FRET efficiency (F-604/F-510 ratio) was tested within linear dynamic range from 5 to 50 nM with detection limit down to 50 pM. Assembled biosensor was then successfully employed for sarcosine quantification in prostatic cell lines (PC3, 22Rv1, PNT1A), and urinary samples of prostate adenocarcinoma patients.
Links
ED1.1.00/02.0068, research and development project |
|